Literature DB >> 1496141

Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial.

S J Arnott1, W Duncan, G R Kerr, P R Walbaum, E Cameron, W J Jack, W J Mackillop.   

Abstract

One-hundred-and-seventy-six patients with potentially operable squamous cell carcinoma or adenocarcinoma of the middle or lower thirds of the oesophagus were randomly assigned to preoperative radiotherapy or surgery alone. Patients assigned to the radiotherapy arm received 20 Gy in 10 treatments over 2 weeks, using parallel opposed 4 MV beams. The preoperative radiotherapy was not associated with any significant acute morbidity or any increase in operative complications. The median survival of the overall group of 176 patients was 8 months, and the 5-year survival was 13%. There was no significant difference in the survival of the 90 patients who received preoperative radiotherapy and the 86 who were managed by surgery alone. Proportional hazards analysis identified lymph node involvement, high tumour grade and male sex as significant adverse prognostic features, but the treatment option assigned had no prognostic significance. It was concluded that low dose preoperative radiotherapy offered no advantage over surgery alone.

Entities:  

Mesh:

Year:  1992        PMID: 1496141     DOI: 10.1016/0167-8140(92)90287-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  34 in total

1.  Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.

Authors:  Dong-Bin Wang; Xun Zhang; Hong-Li Han; Yi-Jun Xu; Da-Qiang Sun; Zhen-Liang Shi
Journal:  Dig Dis Sci       Date:  2012-06-14       Impact factor: 3.199

Review 2.  Neoadjuvant treatment of esophageal cancer.

Authors:  Nicholas P Campbell; Victoria M Villaflor
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

3.  [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].

Authors:  F Lordick
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 4.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 5.  Perioperative therapy for esophageal cancer.

Authors:  Makoto Yamasaki; Hiroshi Miyata; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-29

Review 6.  Role of radiotherapy in the pre-operative management of carcinoma of the esophagus.

Authors:  Bryan H Burmeister
Journal:  World J Gastrointest Oncol       Date:  2015-01-15

7.  Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results.

Authors:  Nicolas Plaisant; Pierre Senesse; David Azria; Claire Lemanski; Marc Ychou; Francois Quenet; Bernard Saint-Aubert; Philippe Rouanet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

8.  Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

Authors:  Philip W Y Chiu; Angus C W Chan; S F Leung; H T Leong; K H Kwong; Micheal K W Li; Alex C M Au-Yeung; Sydney C S Chung; Enders K W Ng
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

9.  The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis.

Authors:  Jeremiah T Martin; Mathias Worni; Joseph B Zwischenberger; Beat Gloor; Ricardo Pietrobon; Thomas A D'Amico; Mark F Berry
Journal:  Ann Thorac Surg       Date:  2012-10-11       Impact factor: 4.330

Review 10.  Multimodality approach for locally advanced esophageal cancer.

Authors:  Khaldoun Almhanna; Jonathan R Strosberg
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.